clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2024-102-5-6-400-409clinmed-856Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESРоль шкал оценки риска кровотечения в прогнозировании развития осложнений в кардиохирургииPreoperative bleeding risk assessment in cardiac surgery patientsЗюзинВ. С.ZyuzinV. S.

Зюзин Вадим Сергеевич — врач высшей квалификационной категории, заведующий трансфузиологическим кабинетом

Калининград

Vadim S. Zyuzin — doctor of the highest qualifi cation category, head of the transfusiological offi ce

Kaliningrad

zuruss@mail.ruФГБУ «Федеральный центр высоких медицинских технологий» Минздрава РоссииРоссияFederal Center of High Medical TechnologiesRussian Federation2024071120241025-6400409Copyright © Зюзин В.С., 20242024Зюзин В.С.Zyuzin V.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/856

Одно из ключевых значений в достижении результатов лечения в кардиохирургии занимает оценка риска предполагаемого кровотечения. Предоперационная анемия, интраоперационная кровопотеря и трансфузионная терапия, являясь независимыми факторами риска неблагоприятных исходов, обладают кумулятивным эффектом. Учитывая ограниченную клиническую эффективность рутинных коагуляционных тестов, необходим мультимодальный, пациентоориентированный подход. Факторы, влияющие на риск кровотечения, должны рассматриваться с позиций как связанных с индивидуальными особенностями пациента, так с видом и объемом планируемого хирургического вмешательства. Оценка риска кровотечения должна базироваться на информации индивидуального и наследственного анамнеза, анализе предыдущих кровотечений. В связи с этим особая роль отводится информации, полученной с использованием шкал оценки риска кровотечения.

One of the most important aspects in achieving successful outcomes in cardiac surgery is the evaluation of the risk of bleeding during and after the procedure. Preoperative anemia, intraoperative bleeding, and transfusion therapy contribute to a cumulative risk of adverse events. Given the limitations of traditional coagulation tests, a more comprehensive and patient-centered approach is necessary. Factors affecting the risk of bleeding should be considered from the perspective of both individual patient characteristics and the specific type and extent of the planned surgical intervention. The risk assessment should be informed by individual and familial history, as well as previous episodes of bleeding or other relevant information. The use of bleeding risk scales can play a crucial role in this process, providing valuable insights into the likelihood of bleeding complications. In conclusion, a comprehensive approach that takes into account the unique characteristics of each patient and the specific details of the surgical procedure is essential for minimizing the risk of complications and ensuring successful outcomes.

подготовка пациента к оперативному вмешательствупредоперационная оценка риска кровотеченияшкалы оценки риска кровотечениягемостазтрансфузиякомпоненты кровиpreparing the patient for surgerypreoperative bleeding risk assessmenttransfusionblood componentsReferencesAntwi-Kusi A., Addison W., Obasuyi B.I., Domoyeri P. Preoperative Laboratory Testing by Surgeons: Implication on Anaesthetic Management. International Journal of Clinical Medicine. 2019;10:345–52.Antwi-Kusi A., Addison W., Obasuyi B.I., Domoyeri P. Preoperative Laboratory Testing by Surgeons: Implication on Anaesthetic Management. International Journal of Clinical Medicine. 2019;10:345–52.Martin S.K., Cifu A.S. Routine preoperative laboratory tests for elective surgery. JAMA. 2017:8:567–8.Martin S.K., Cifu A.S. Routine preoperative laboratory tests for elective surgery. JAMA. 2017:8:567–8.Bohmer AB., Wappler F., Zwissler B. Preoperative Risk Assessment — From Routine Tests to Individualized Investigation. Dtsch. Arztebl. Int. 2014;111(25):437–46.Bohmer AB., Wappler F., Zwissler B. Preoperative Risk Assessment — From Routine Tests to Individualized Investigation. Dtsch. Arztebl. Int. 2014;111(25):437–46.Liontos L., Fralick M., Longmore A. et al. Bleeding Risk Using INR.aPTT Pre-Surgery: Systematic Review (BRUISR). Blood. 2017;130(1):4654–4656.Liontos L., Fralick M., Longmore A. et al. Bleeding Risk Using INR.aPTT Pre-Surgery: Systematic Review (BRUISR). Blood. 2017;130(1):4654–4656.Haas T., Fries D., Tanaka K.A. et al. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br. J. Anaesth. 2015;114(2):217–224.Haas T., Fries D., Tanaka K.A. et al. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence? Br. J. Anaesth. 2015;114(2):217–224.Curnow J., Pasalic L., Favaloro EJ. Why do patients bleed? Surg. J. (N.-Y.). 2016;2(1):29–43.Curnow J., Pasalic L., Favaloro EJ. Why do patients bleed? Surg. J. (N.-Y.). 2016;2(1):29–43.National Blood Authority. Preoperative Bleeding Risk Assessment Tool. Canberra ACT: National Blood Authority Australia. 2015.National Blood Authority. Preoperative Bleeding Risk Assessment Tool. Canberra ACT: National Blood Authority Australia. 2015.Safiri S., Kolahi A.-A., Noori M. ,Nejadghaderi S.A., Karamzad N., Bragazzi N.L. et al. Burden of anemia and its underlying causes in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019. J. Hematol. Oncol. 2021;14(1):185. DOI: 10.1186/s13045-021-01202-2Safiri S., Kolahi A.-A., Noori M. ,Nejadghaderi S.A., Karamzad N., Bragazzi N.L. et al. Burden of anemia and its underlying causes in 204 countries and territories, 1990–2019: results from the Global Burden of Disease Study 2019. J. Hematol. Oncol. 2021;14(1):185. DOI: 10.1186/s13045-021-01202-2Здравоохранение в России. Под ред. Смелова П.А. М., Стат. сб. Росстат 2021:171.Healthcare in Russia. Ed. Smelov P.A. M., Stat. sat. Rosstat 2021:171. (In Russian)Munting K.E., Klein A.A. Optimisation of pre‐operative anaemia in patients before elective major surgery – why, who, when and how? Anaesthesia. 2019;74(1):49–57.Munting K.E., Klein A.A. Optimisation of pre‐operative anaemia in patients before elective major surgery – why, who, when and how? Anaesthesia. 2019;74(1):49–57.http://uptodate.com.contents.perioperative-blood-management-strategies-to-minimize-transfusionshttp://uptodate.com.contents.perioperative-blood-management-strategies-to-minimize-transfusionsИдельсон Л.И., Воробьев П.А. Железодефицитные анемии. Руководство по гематологии. Под ред. Воробьева В.И. М., Ньюдиамед; 2005:171–190.Idelson L.I., Vorobyov P.A. Iron deficiency anemia. A guide to hematology. ed. Vorobyova V.I. M., Newdiamed; 2005:171–190. (In Russian).Cappellini M.D., Musallam K.M., Taher A.T. Iron deficiency anaemia revisited. J. Intern. Med. 2020;287(2):153–170.Cappellini M.D., Musallam K.M., Taher A.T. Iron deficiency anaemia revisited. J. Intern. Med. 2020;287(2):153–170.Goddard A.F., James M.W., McIntyre A.S., Scott B.B. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60:1309–1316.Goddard A.F., James M.W., McIntyre A.S., Scott B.B. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60:1309–1316.Купряшов А.А., Самуилова О.В., Самуилова Д.Ш. Бережное отношение к крови больного как приоритетная стратегия в кардиохирургии. Гематология и трансфузиология. 2021; 66(3):395–416.Kudryashov A.A., Samoilova O.V., Samuilova D.S. Careful treatment of the patient’s blood as a priority strategy in cardiac surgery. Hematology and transfusiology. 2021;66(3):395–416. (In Russian). DOI: 10.35754.0234-5730-2021-66-3-395-416Raphael J., Mazer C.D., Wilkey A. et al. Corrigendum to ‘Society of Cardiovascular Anesthesiologists (SCA) Clinical Practice Improvement (CPI) Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients’ [Journal of Cardiothoracic and Vascular Anesthesia 2019;33:2887–2899]. J. Cardiothorac. Vasc. Anesth. 2020;34(3):840–841. DOI: 10.1053.j.jvca.2019.11.004Raphael J., Mazer C.D., Wilkey A. et al. Corrigendum to ‘Society of Cardiovascular Anesthesiologists (SCA) Clinical Practice Improvement (CPI) Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients’ [Journal of Cardiothoracic and Vascular Anesthesia 2019;33:2887–2899]. J. Cardiothorac. Vasc. Anesth. 2020;34(3):840–841. DOI: 10.1053.j.jvca.2019.11.004Estcourt L.J., Roberts D.J. Six-month outcomes after restrictive or liberal transfusion for cardiac surgery (TRICS III trial). Transfus. Med. 2019;29(2):77–79.Estcourt L.J., Roberts D.J. Six-month outcomes after restrictive or liberal transfusion for cardiac surgery (TRICS III trial). Transfus. Med. 2019;29(2):77–79.Leahy MF., Hofmann A., Towler S. et al. Improved outcomes and reduced costs associated with a healthsystem–wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347–1358.Leahy MF., Hofmann A., Towler S. et al. Improved outcomes and reduced costs associated with a healthsystem–wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347–1358.https://uptodate.com.contents.preoperative-medical-evaluation-of-the-healthy-adult-patienthttps://uptodate.com.contents.preoperative-medical-evaluation-of-the-healthy-adult-patientZhang Q., Gao S., Diao X. et al. Dose-dependent influence of red blood cell transfusion volume on adverse outcomes in cardiac surgery. Perfusion. 2023;38(7):1436 –1443.Zhang Q., Gao S., Diao X. et al. Dose-dependent influence of red blood cell transfusion volume on adverse outcomes in cardiac surgery. Perfusion. 2023;38(7):1436 –1443.Shehata N., Mistry N., da Costa BR., Pereira T.V. et al. Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. Eur. Heart J. 2019;40(13):1081–1088.Shehata N., Mistry N., da Costa BR., Pereira T.V. et al. Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis. Eur. Heart J. 2019;40(13):1081–1088.Stierer T.L., Collop N.A. Preoperative testing and risk assessment: perspectives on patient selection in ambulatory anesthetic procedures. Ambulatory Anesthesia. 2015;2:67–77.Stierer T.L., Collop N.A. Preoperative testing and risk assessment: perspectives on patient selection in ambulatory anesthetic procedures. Ambulatory Anesthesia. 2015;2:67–77.Rydz N., James P.D. The evolution and value of bleeding assessment tools. J. Thromb. Haemost. 2012;10(11):2223–2229.Rydz N., James P.D. The evolution and value of bleeding assessment tools. J. Thromb. Haemost. 2012;10(11):2223–2229.Han, Binru et al. Effects of the frailty phenotype on post-operative complications in older surgical patients: a systematic review and meta-analysis. BMC geriatrics. 2019;19(1):141. DOI: 10.1186.s12877-019-1153-8Han, Binru et al. Effects of the frailty phenotype on post-operative complications in older surgical patients: a systematic review and meta-analysis. BMC geriatrics. 2019;19(1):141. DOI: 10.1186.s12877-019-1153-8Bennett J., Fung D., Hodson R., Agarwal A. Implementation of a Surgical Liaison Service for Elderly Patients: A Single Unit Experience. Geriatrics (Basel). 2019;4(3).Bennett J., Fung D., Hodson R., Agarwal A. Implementation of a Surgical Liaison Service for Elderly Patients: A Single Unit Experience. Geriatrics (Basel). 2019;4(3).Fasulo M.R., Biguzzi E., Abbattista M. et al. The ISTH Bleeding Assessment Tool and the risk of future bleeding. J. Thromb. Haemost. 2018;16(1):125–130.Fasulo M.R., Biguzzi E., Abbattista M. et al. The ISTH Bleeding Assessment Tool and the risk of future bleeding. J. Thromb. Haemost. 2018;16(1):125–130.Elbatarny M., Mollah S., Grabell J. et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831–835.Elbatarny M., Mollah S., Grabell J. et al. Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project. Haemophilia. 2014;20(6):831–835.National Blood Authority. Preoperative Bleeding Risk Assessment Tool. Canberra ACT, National Blood Authority Australia. 2015.National Blood Authority. Preoperative Bleeding Risk Assessment Tool. Canberra ACT, National Blood Authority Australia. 2015.Adler M., Kaufmann J., Alberio L., Nagler M. Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders. J. Thromb. Haemost. 2019;17(7):1104–1112.Adler M., Kaufmann J., Alberio L., Nagler M. Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders. J. Thromb. Haemost. 2019;17(7):1104–1112.Curnow J., Pasalic L., Favaloro E.J. Why do patients bleed? Surg. J. (N.-Y.). 2016;2(1):29–43.Curnow J., Pasalic L., Favaloro E.J. Why do patients bleed? Surg. J. (N.-Y.). 2016;2(1):29–43.Spyropoulos A.C., Al-Badri A., Sherwood M.W., Douketis J.D. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an electiveprocedure or surgery. J. Thromb. Haemost. 2016;14(5):875–885.Spyropoulos A.C., Al-Badri A., Sherwood M.W., Douketis J.D. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an electiveprocedure or surgery. J. Thromb. Haemost. 2016;14(5):875–885.

The authors declare that there are no conflicts of interest present.